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SELECTION CRITERIA
To be eligible, studies had to assess the effects of any substitution therapy (using e.g. methadone and/or opiates as substitution drugs). Only effects on offending have been considered. Comparisons of competing treatments (substitution therapy vs. any other form of treatment, including placebo treatment or no treatment at all) were restricted to studies meeting level 4 or higher on the scale developed by Sherman et al. (1997) . In addition, one-group pre-post evaluations of substitution therapies were included because changes in offending are substantial compared to pre-treatment levels, while comparisons of treatment with several substances often show modest differences. Finally, studies that assessed the impact of drug substitution at the macro (i.e. city or regional) level were also included. The three different types of studies have been analyzed separately.
DATA COLLECTION AND A NALYSIS
66 studies were considered, and 46 were selected for inclusion in the review. They separately assess the impact of methadone, buprenorphine, heroin, naltrexone, dihydrocodeine or Levo-alpha-acetylmethadone substitution on the criminal behaviour of opiates addicts. Meta-analytic techniques were used to identify overall effects of several substances. Comparisons of different treatments (i.e. substitution vs. any other treatment) were restricted to studies meeting levels 4 or 5 on the scale developed by Sherman et al. (1997) .
MAIN RESULTS
Heroin maintenance reduces crime significantly more than Methadone maintenance. Methadone maintenance reduces offending more than treatments without substitution therapy, but the mean effect size is not significant (p >.1). However, very large (and significant) reductions in criminal behaviour are observed during methadone maintenance therapy with respect to pre-treatment levels. Buprenorphine does not significantly reduce criminal behaviour, although effects are positive, be it with respect to methadone or a placebo. Naltrexone treatment reduces criminality significantly more than behaviour therapy or counselling.
CONCLUSION
Heroin maintenance has been found to significantly reduce criminal involvement among treated subjects, and it is more effective in crime reduction than methadone maintenance. Methadone maintenance greatly reduces criminal involvement, but apparently not significantly more so than other interventions. Buprenorphine and Naltrexone have been found to be promising, although few studies have been identified using these substances in maintenance treatment.
Background of the Review
For the last decades, drug addiction has become an increasingly worrying problem throughout the Western World. Drug-addicts have been disproportionately involved in criminal activities, making drug-addiction, beyond public health concerns, a formidable challenge to public order. In 8 European countries, burglaries, robberies and other serious crimes increased by several hundred percent between 1970 and 2000 (Killias, 2002, p.115) . Comparison of self-reported delinquency in 7 countries (Killias & Ribeaud 1999) suggest that the extent of involvement in property crime among addicts of any kind of hard drugs is about 10 times higher than among nonusers. Thus, the increasing trends of robbery and burglary in many Western countries between 1970 and 1995 may reasonably also be seen as a side-effect of increasing drug use.
In response to this phenomenon, numerous programs have been set up to provide drug addicts with narcotics (e.g., heroin prescription programs) and substitution drugs. The intended goals of such treatments have been:
(1) to improve drug users' quality of life, reducing the risks of overdose or contagious diseases, controlling the quality of drugs available on local markets, preventing marginalization and improving social integration, (2) to diminish social costs of drug addiction, (3) to reduce drug-related offences and protect public order. It is assumed that drug addicts commit many predatory offences mainly to finance the purchase of drugs, and that criminality will decrease once drugs are supplied to addicts through official channels. The same effect should be observed if drug addicts are supplied with products (such as methadone) that suppress physical effects of withdrawal and, indirectly, the immediate need to consume drugs, (4) to reduce public order problems of all sorts. If addicts obtain drugs through official channels, they should spend less time in the search for drugs, which means that they have more time available for legitimate earnings and will less concentrate in places where addicts and dealers regularly gather (e.g., "needle" parks in Switzerland).
Many researchers have studied the effects of drug prescription programs on criminal behaviour among participants. We shall review these programs and try to find out whether they have been effective in reducing criminality.
Objectives of the Review
The review aims at evaluating the effects of drug prescription and substitution programs on criminal behaviour among participants. To be included in this review, studies have to assess the effects of drug substitution on offending. If this review reveals significant effects of such programs on criminality, the results could have implications for crime and justice as well as for drug policies. For example, if the results of our meta-analysis support the conclusion that heroin maintenance reduces criminality, medical prescription of heroin could be an option in the treatment of severely addicted drug users with high criminal involvement whenever reductions in offending is among the priorities. Furthermore, the bibliographies of relevant reviews (Amato et al., 2005; Farrell et al., 1994; Ferri, 2005; Hall, 1998; Holloway, 2005; Kosten et al., 1993; Luty, 2003; Prendergast, 2002) have been consulted.
The keywords that have guided the search for references in databases and bibliographies were the following: drug addiction; drug prescription; substitution programs; controlled trial; re-offending; heroin; methadone; opiates, treatment programs; drug abuse; drug addict, heroin prescription, property crime, cocaine abuse; dexamphetamine; cocaine substitution. In addition, the following combinations of keywords have been used: substitution program + re-offending; heroin + treatment programs; heroin + substitution program; heroin + methadone; opiates + treatment; opiates + substitution; heroin + property crime; substitution programs + property crime, cocaine abuse + dexamphetamine.
Being that the staff of the University of Zurich Institute for Criminology and Criminal Law is multi-lingual, studies published in any of the following languages were eligible for inclusion: English, French, German, Dutch, Italian, Spanish, Portuguese, Romanian, Polish, Ukrainian and Russian. In the protocol, it was foreseen that contacts would be established through international channels, such as the European Sourcebook Group (with its network of correspondents in more than 40 countries), the European Society of Criminology and the International Society of Criminology, with countries not routinely covered in international reviews of research. No relevant studies were identified through these channels, however. Studies published in any language after 1960 have been considered.
CRITERIA F OR INCLUSI ON AND EXCLUSION OF STUDIES IN THE REVIE W
Randomized studies, quasi-experimental studies and before-after comparisons on the effects on offending of drug substitution programs have been included. Interventions can be court-ordered or unrelated to any involvement of the criminal justice system. Only interventions based on substitution programs (using e.g. methadone and/or opiates as substitution drugs) will be considered. Possible effects beyond offending have not been considered, in particular eventual medical outcomes. A coding protocol was prepared along the guidelines of the Campbell Collaboration. Moreover, our review complies with the current standards of metaanalysis (e.g. as specified in Practical Meta-Analysis by Lipsey & Wilson) .
TYPES OF STUDIES
Studies meeting level 4 or higher on the scale developed by Sherman et al. (1997) have been considered for comparing competing treatments. In addition and in order to give the reader the full picture, pre-post studies have been included and mean effect sizes have been computed. Such studies are useful in the present context because changes in offending are often substantial compared to pre-treatment levels, while comparisons of treatment with several substances often show modest differences.
Thus, the following types of studies have been included:
(1) One-group, pre/post studies: studies comparing individual delinquency rates before, during and following treatment. To be eligible, studies had to include the prescription of a drug (e.g., methadone, heroin). (2) Multi-group comparison studies, including both true experimental studies (randomized designs) and quasi-experimental designs: studies comparing delinquency rates among subjects of an experimental group before, during and following treatment to those of a control group (with or without random assignment). As in the previous paragraph, studies were eligible only if the treatment group underwent substitution therapy.
As a control group, we considered any group undergoing an alternative treatment or no treatment at all (including placebo control). For example, if the treatment group was treated with heroin as a substitution drug, the control group could remain untreated or may have received any other substance as a substitution drug (e.g., methadone). It may also have undergone abstinence therapy with or without psychotherapy, detoxification, etc. (3) Macro level studies: studies assessing the impact of drug substitution at the macro (i.e. city, regional) level. In order to be eligible, such studies needed to measure the impact of the program on delinquency at the city/regional level, using police, court or survey data.
The three different types of studies have been analyzed separately. All of the studies taken into account assess the effects of drug substitution programs on offending.
The inclusion criteria have been restrained with respect to the protocol due to the large number of studies of levels 2 and 3. Whereas pre-post studies have been summarized below (Table 5) , studies of level 3 have been dropped since a sufficient number of high-quality group comparisons (levels 4 and 5) have been identified (Tables 1, 2 , 3 and 6).
TYPES OF PROGRAMS

Type of intervention
Studies reporting effects of drug prescription and drug substitution programs on criminality among drug users have been included. By drug substitution program we understand programs that include the prescription of substances rather than programs based on drug abstinence. Methadone detoxification has not been considered as a substitution program, since the finality is abstinence and doses of methadone are reduced to zero after a relatively short period. The prescription must imply substances considered as substitutes for illegal drugs, for example, methadone or buprenorphine as a substitute of heroin. This excludes the prescription of drugs such as tranquillizers or antibiotics, frequently prescribed to drug users. However, studies using Naltrexone®, an opioid antagonist, have been included as well. The medically assisted prescription of heroin has also been included. This does not mean that heroin is a substitute of heroin, but that the uncontrolled consumption of heroin in the streets is replaced by the prescription of a controlled dosage of heroin, adapted to the user's needs.
Programs that do not include prescription of any substance have not been considered, such as programs based exclusively on, for example, psychotherapy, detoxification, etc, except in control groups where the treatment group underwent a substitution intervention. Only interventions based on substitution therapy (using e.g. methadone and/or opiates as substitution drugs) have been considered.
Kinds of drugs to be substituted by programs
All drugs that are illegal according to international agreements and local (national) laws, such as heroin, morphine, opium, cocaine, crack, ecstasy, amphetamine, LSD, ketamine, cannabis, fentanyl, inhalants etc.
Context of programs
Any program, no matter whether treatment is court-ordered or unrelated to any involvement of the criminal justice system. Programs involving incarcerated drugaddicts have not been considered since re-offending cannot be adequately tested as long as offenders remain in prison. Studies where treatment commences in prison but re-offending is measured after release have been included.
TYPES OF OUTCOME MEA SURES
The key outcome measure considered is offending as measured by reconviction data, police records and studies on self-reported delinquency. Drug possession and consumption has not been considered expressly as a measure of offending although it is an offence in most countries. Since in many studies the overall number of crimes (as measured by self reports, arrests, convictions or incarcerations) is reported, drug possession and consumption is certainly included in some of these general outcome measures. To the extent that studies address the effects at the macro level, any conventional outcome measures (statistics, crime victim surveys etc.) have been considered.
To assess improvement at the individual level, prevalence rates (or percentage of people who re-offend) as well as incidence rates (or number of offences committed per person) during standardized pre-and post-intervention periods have been considered. Prevalence rates inform on how many persons are diverted from criminal activity by prescription of substitution products, whereas incidence rates allow assessing whether fewer offences are committed as a result of the program. It is important to make this distinction since a given program may reduce the number of offences without affecting the number of offenders. Possible treatment effects beyond offending, such as medical outcomes or effects of such programs on drug markets have not been considered.
TYPES OF PARTICIPANT S
The considered population consists of drug-addicts (e.g. heroin addicts, cocaine addicts), adults and adolescents, males and females.
DESCRIPTION OF METHO DS USED IN THE COMPONENT STU DIES
The methods used by the studies covered by this review can be the following ones: Randomized studies, quasi-experimental studies and before-after comparisons.
All studies included in this review will have a measure of the effects of drug substitution treatments on offending such as arrest, conviction, incarceration or selfreports.
CRITERIA F OR DETERMI NATION OF INDEPENDEN T FINDINGS
There are three potential sources of non-independence of findings. We shall use the same criteria as in similar Campbell Review Protocols (e.g. Lipsey and Landenberger (2006) ; Wilson et al.(2007) ).
The first potential source of non-independence of findings is multiple indicators of offending reported from a single study (e.g. arrest, conviction). When more than one such outcome is reported, only one will be selected for the analysis. To maintain as much comparability as possible across studies, coders have selected the outcome measure that is most frequently represented in other studies in the collection (Lipsey et al., 2006) . This has been "all offences", measured usually at the level of arrests or self-reports. If "all offences" was not available, any among several outcomes was selected randomly.
The second occurs when the same outcome is measured at multiple points in time, e.g., 6-months, 12-months, 18-months and two years post-treatment. In those cases, the measure with the timing closest to that most commonly used across all the studies (12 months) has been chosen to maximize comparability between studies (Lipsey et al., 2006) .
Finally, the third source of non-independent findings is the same data being reported across multiple documents. We have used author's names, court location and study time frames as well as sample descriptions to identify multiple publications of the same evaluation. When such multiple publications were identified, the most complete and detailed manuscript was designated as the primary coding source. Additional manuscripts have been consulted to elaborate coding if necessary (Wilson et al., 2007) .
DETAILS OF STUDY CODING CATEGOR IES
A coding protocol was developed for this synthesis that provides for a systematic method of extracting information regarding each study's research design, program, nature of the outcome measure, and outcome data (see appendix-Coding Protocol).
STATISTICAL PROCEDUR ES AND CONVENTIONS
Our review complies with the current standards of meta-analysis (e.g. as specified in Practical Meta-Analysis by Lipsey & Wilson) .
The three types of studies mentioned above (pre/post studies, randomized controlled trials and quasi-experimental designs, and macro-level studies) have been synthesized and meta-analyzed separately.
The effect of drug prescription or substitution programs on criminal behaviour was encoded using the odds-ratio. The odds-ratio is well suited to dichotomous outcomes, such as those commonly used in drug treatment. When offending was measured (quasi-) continuously (crime days, number of arrests), a standardized mean difference type effect size was computed and transformed into an odds-ratio (see Lipsey & Wilson, 2001 ). For pre-post studies, odds ratios have been computed between t0 and t1. An odds ratio of >1.0 indicates that treatment reduced offending, and an odds ratio of <1.0 was used whenever treatment was unsuccessful. Effect size outliers (›± 3.0 standard deviations) would have been winsorized to less extreme values (next highest not judged an outlier); however, no such outliers were observed. In addition, no data were imputed for missing values.
For the computation of mean-effect sizes, the inverse variance method of metaanalysis (Lipsey & Wilson, 2001 ) was used. In the first place, fixed-effect models were fitted. Whenever the Q-test refuted homogeneity, a random effects model was adopted.
TREATMENT OF QUALITA TIVE RESEARCH
No qualitative research was included in this systematic review.
Findings
OVERVIEW
In Medline, 3,791 studies have been found using the searches with combined keywords. All different searching strategies together yielded 459 references to be retained for further examination; 68 are reviews, 220 have been rejected as being out of the scope of the present review (of these, 168 are available as full text versions), and 171 have been retained as being of interest (of these, 152 are available as full text). Among the 171 references retained, there are cases where several articles refer to a same study, while not necessarily reporting the same results. Sixtysix studies have been coded. 46 of these either fulfil criteria of Sherman 4 or higher or are pre-post comparisons or population studies and have therefore been included in the present review.
EFFECTS OF HEROIN SU BSTITUTION TREATMENT
Among the coded eligible studies, 6 concern Heroin substitution programs, and 5 are randomized controlled trials (RCTs). In four of the RCTs, the control group undergoes methadone maintenance (Dijkgraaf, 2005; Hartnoll et al., 1980; Löbmann et al., 2008; March et al., 2006) , while in one (Perneger, 1998 ) the control group undergoes any conventional treatment (mostly Methadone maintenance treatment, MMT). A general description of these studies is available in the appendix, Table A1 . One study is an intake-follow up investigation of the efficacy of Heroin (Killias et al., 1999) . It was excluded from the models shown below. The effect sizes retained for these studies as well as the Random-and Fixed effects model effect sizes are reported in Table 1 below. The standard deviation for all effects is 14.04; none of the studies was therefore winsorized. However, the study by Perneger (1998) includes 21 subjects in control group, and 27 in the treatment group; also, the confidence interval for this odds ratio is [5.52;203.6] and therefore, effects observed are very variable, certainly due to (1) the heterogeneous control group and (2) a small sample size. The Killias et al.
(1999) study may have a higher effect size because subjects in the Swiss heroin trial were selected for treatment considering particularly their high criminal involvement.
The hypothesis of homogeneity is here rejected. If Perneger (1998) is not included in the analysis, due to the different treatment of the control group with respect to all other included studies, homogeneity is accepted. The Fixed effects mean effect size is then 1.55 [1.18; 2.02] (p=0.0015). Here, a significant decrease in the criminality measures is, therefore, present for Heroin rather than Methadone maintenance.
EFFECTS OF BUPRENOR PHINE SU BSTITUTION TREATMENT
For the effect of Buprenorphine on criminal behaviour, 4 studies have been found. 3 of these are RCTs. In two, the control group is in MMT (Harris et al., 2005; Magura et al., 2008 , while in the third (Krook, 2002) , the control group receives a placebo only. The individual and overall effects are shown in Table 2 below, while general descriptors of the studies are presented in the Appendix (Table A2 ). The fourth study (Kakko et al., 2003 ) is a randomized controlled trial as well, but the measure of criminality is only given for the treatment group in pre-post form. Harris (2005) Krook (2002) Magura ( The hypothesis of homogeneity is refuted (Q test p=0.0033), and when the study with a differing control group (Krook et al., 2002 ) is excluded, this remains so (Q test p=0.0008). Overall, there is therefore no significant reduction in criminality when Buprenorphine instead of Methadone is used, although the effects have a tendency to be positive with Buprenorphine with respect to Methadone (or Placebo).
METHADONE MAINTENANC E TREATMENT (MMT)
For methadone maintenance, 41 studies have been found and coded; 2 of these are population studies, 11 are quasi-experimental studies (but 8 are Sherman 2 or 3 and have therefore been excluded, since a large number of studies have been found), 21 are pre-post studies and 7 RCTs. The included studies are 7 RCTs and 3 quasiexperimental studies. Among the RCTs, the control groups differ widely: three are waiting-list controls (Dole et al., 1969; Schwartz et al., 2007; Yancovitz et al., 1991) , in one the control group receives a placebo (R. Newman et al., 1979) , in one the control group receives counselling (Kinlock, 2008) , in one the control group receives detoxification (Sees et al., 2000) , and in one the control is treatment community (Bale et al., 1980) . Among the quasi experimental studies, two controls are detoxification (Daley, 2000; Haglund et al., 1978) and one residential treatment (Teesson, 2006) . A general description of these studies is given in the Appendix, Table A3 . Dole (1969) and Yankovitz (1991) 
are cut for the representation (arrows).
Daley (2000) Teesson (2006) Haglund (1987) Kinlock (2008) Dole (1969) Bale (1980) Newman (1979) Schwartz (2007) Yankowitz ( Again, homogeneity analysis refutes the hypothesis of homogeneity (p=0.0047). The random effects model does not indicate a significant effect of methadone maintenance with respect to these control groups; the mean effect measure is, however, in favour of Methadone maintenance.
When groups are analysed separately by control groups, the between group variability is not significant. Also, homogeneity is not rejected for the detoxification (p=0.35) and counselling/residential treatment / treatment community (TC) control groups (p=0.63). Detailed results are given in table 4. Therefore, Methadone maintenance has no significantly better effect on criminality than any of these control treatments. Also, a non-significant but positive effect of Methadone maintenance over all other control conditions is detected.
In table 5, the results for the pre-post (or rather, during) studies using methadone are reported. One of these studies is a randomized controlled trial of oral versus intravenous methadone delivery (Strang et al., 2000) ; only the pre-post results of the oral methadone group are presented here, since it was decided to compare different substances of substitution rather than dosages or ways of administration. Effect sizes (log odds ratios) have been computed by comparing pre-treatment levels of offending and average individual offending rates during maintenance treatment. This explains the sometimes very large odds ratios obtained. Also, the maximum effect size obtained (1081) is observed in a study with only 24 participants. Walger (1989) and Sheerin (2004) 
have been cut for representation (arrows).
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The hypothesis of homogeneity is again rejected. Here, a beneficial effect of methadone maintenance is observed with respect to baseline. This in no way contradicts results obtained above, where Methadone is not significantly more effective than other substances in reducing criminality; indeed, these pre-post studies only show decreasing criminality during treatment, not whether this is a comparatively effective treatment or even whether the effect is due to being in treatment or to the passage of time.
As for the two population studies, only general results will be reported here since none includes comparison macro units. The first one, carried out by Niveau et al (2002) reports a significant positive correlation of crime known to the police in Geneva with the number of addicts in MMT (with r of 0.71 [0.73; 0.68]). In a reaction, however, Aebi (2001) observed that the overall population of drug addicts needs to be taken into account in such a trend analysis. When this is done, the effect turns in favour of MMT with a significant r of -0.19 [-0.14;-0.24] . In the second population study (Maddux & Desmond, 1979) , a negative correlation is obtained, with an r of -0.93 [-1.03, -0.84].
EFFECTS OF NALTREXON E TREATMENT
While Naltrexone is not a substitution treatment (rather the prescription of an inhibiting substance) it is included; effects are shown in table 6. Two RCTs have been found, one contrasting Naltrexone with counselling (Cornish et al., 1997) and one with behaviour therapy (Rawson, 1979) ; also, one pre-post trial is shown in table 6 (De Jong et al., 2007) . The descriptors of the studies included in the meta-analysis are given in the Appendix, Table A4 . Here, homogeneity is not rejected by the test; Naltrexone is here shown to have a significant and beneficial effect on criminal behaviour with respect to psychological interventions.
EFFECTS OF OTHER SUB STITUTION TREATMENTS
Finally, two RCTs have been found that use other replacement therapies: one where Levo-alpha-acetylmethadone (LAAM) is compared to MMT (Eissenberg et al., 1997) and one where MMT is compared to Dihydrocodeine (Robertson et al., 2006) . In the first case, the effect favours LAAM; the effect size is 1. 93 [0.16, 22.31 ] and the effect is not significant. However, very serious side-effects (torsade de pointes) have been observed with this substitution drug that is, for this reason, unavailable in Europe.
In the second case, the effect size is 0.96 [0.39; 2.37] and is not significant either.
Discussion
Two systematic reviews of substitution programs have been carried out to be included in the Cochrane database of systematic reviews: Ferri et al (2006) and Mattick et al (2006) . While these reviews do not focus on delinquency as an outcome measure, a comparison of results with the present report seems relevant. In Ferri et al (2006) , 4 trials comparing methadone maintenance to Heroin maintenance are included. One study showed a reduction in the risk of being charged when on Heroin maintenance; this in line with the results obtained here. Also, two studies considered criminal offending and social functioning in a multi domain outcome measure, and again, heroin plus methadone maintenance yields better results than methadone alone. Again, this is in line with the results obtained here, i.e. heroin maintenance reduced criminality more than other maintenance treatments.
In Mattick et al (2006) , three studies comparing methadone maintenance to no opioid replacement therapy with respect to their effect on criminal behaviour are included. The results obtained are similar to the results obtained here in two respects: firstly, the effect of methadone maintenance seems to reduce criminal behaviour more than the alternatives, and secondly, this effect is not significant.
Conclusion
Heroin maintenance reduces crime significantly more than Methadone maintenance. Methadone maintenance itself does not have a significant effect on criminal behaviour; in particular with respect to two detoxification and one treatment community program, the effect is even negative. While Methadone maintenance is, with respect to reductions in offending, not to be the preferred treatment, it was found to be promising in comparison to detoxification, treatment community, counselling and residential treatment, placebo and waiting list controls. These reductions are not significant, while very large (and significant) reductions in criminal behaviour are observed during Methadone maintenance with respect to pre-treatment levels.
Buprenorphine does not significantly reduce criminal behaviour, although effects are strictly positive, be it with respect to Methadone or a placebo.
Finally, a quite different treatment has been evaluated here as well: Naltrexone. This treatment reduces criminality significantly more than behaviour therapy or counselling.
Overall, crime reduction among addicts, though important in itself, will probably not be the only goal to give attention to. This review does not address other (possibly different) effects of substitution therapy on other goals, such as promoting abstinence or improving health.
Plans for updating the Review
This review will be updated every five years to include new treatment studies published in any language. The primary authors will take the lead in this update.
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